港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

中醫藥概念

801.891

-0.660-0.08%

漲家數：3

跌家數：7

平家數：1

市盈率：- -

高：810.107

開：803.141

低：795.670

收：802.551

成交量：4,064.85萬

成交額：1.64億

市值：830.28億

流通市值：567.33億

資料載入中...

總覽新聞資訊

百年老字號，左手拆分右手收購

康臣藥業(01681)將於6月22日派發末期股息每股0.4港元

康臣藥業(01681)發布年度業績，股東應占溢利10.78億元按年增加18.41%

培力農本方(01498)發布年度業績淨虧損3522.3萬港元按年收窄0.6%

《盈警》現代中藥集團(1643.HK)料去年轉蝕不少於1,300萬人民幣

阿斯达克财经

現代中藥集團：預計2025年度淨虧損不少於人民幣1300萬元

南方财经网

Modern Chinese Medicine Group FY2025 net result drops to at least RMB13 million loss due to distributor losses and medical insurance list changes

中智藥業(03737)股價上升8.974%，現價港幣$0.85

阿斯达克财经

現代中藥集團(01643)股價上升8.537%，現價港幣$1.78

阿斯达克财经

廣藥白雲山曬成績單：戰略轉向初見成效 2025年營利雙增

21世纪经济报道

培力農本方(01498.HK)完成發行2000萬港元可換股債券

綠葉製藥(02186)出現大手賣出82萬股，成交價$2.32，涉資190.24萬

阿斯达克财经

白雲山「國產偉哥」金戈銷量、收入連續兩年下滑，2025年賣出約7987萬片

红星资本局

中國中藥2025年淨虧損4.58億元營業額下降10.7%

白雲山擬每股派發現金紅利0.45元

《業績》同仁堂國藥(03613.HK)全年純利3.97億元跌20.6% 連特別息派40仙

阿斯达克财经

國藥藥材品牌授權亂象

中国经营网

中國中藥(00570)發布年度業績淨虧損4.58億元按年盈轉虧

白雲山(00874)將派發末期股息每股0.45元

同仁堂國藥(03613)將於6月26日派發末期股息每股0.37港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1606/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","market":"HK","secType":"PLATE","nameCN":"中醫藥概念","latestPrice":801.89105,"timestamp":1774512495612,"preClose":802.5506,"halted":0,"volume":40648500,"delay":0,"changeRate":-0.000822,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":-0.659546,"latestTime":"03-26 16:00:00","open":803.1408,"high":810.1071,"low":795.6703,"amount":163845024,"amplitude":0.017989,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774575000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1774488600000,1774497600000],[1774501200000,1774512000000]],"pbRate":0.856532,"peRate":14.444045,"turnoverRate":0.002592,"increases":3,"decrements":7,"flats":1,"marketCap":83027664960,"floatMarketCap":56732743616},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","high":810.1071,"amplitude":0.017989,"preClose":802.5506,"low":795.6703,"pbRate":"0.856532","latestPrice":801.89105,"volume":40648500,"delay":0,"open":803.1408,"prevYearClose":830.6915,"prevWeekClose":818.111,"prevMonthClose":873.43,"prevQuarterClose":830.692,"fiveDayClose":824.598,"twentyDayClose":870.713,"sixtyDayClose":852.305,"secType":"PLATE","market":"HK","turnoverRate":0.002592,"peRate":14.444045,"marketCap":83027664960,"floatMarketCap":56732743616,"timestamp":1774512495612,"nameCN":"中醫藥概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1606\",,,,undefined,":{"bkCode":"BK1606","up":3,"down":7,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1606\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622883248","title":"百年老字號，左手拆分右手收購","url":"https://stock-news.laohu8.com/highlight/detail?id=2622883248","media":"蓝鲸财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622883248?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 16:06","pubTimestamp":1774512408,"startTime":"0","endTime":"0","summary":"文｜《投资者网》蔡俊百年老字号同仁堂，在进退维谷中。对此，公司责令涉事企业的相关人员辞职。2018年，公司爆发“回收过期蜂蜜”事件，此后业绩下滑，原董事长被查。对此，2025年公司采取多轮变革，核心逻辑是收归利润。2025年前三季度，公司营业收入、归母净利润分别为133.08亿元、11.78亿元，各自同比下降3.7%、12.78%。站在该维度上，2025年以来公司启动的管理层换血、分拆上市、收购补链，或不只是对过去路径依赖的被动修复。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1774448106841990535","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0028","BK0097","BK1583","LU1688375341.USD","BK1191","03613","BK0086","BK0239","BK0183","BK0196","01666","BK0188","600085","BK1606","BK1515","BK0113","BK0012"],"gpt_icon":0},{"id":"2622838695","title":"康臣藥業(01681)將於6月22日派發末期股息每股0.4港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622838695","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622838695?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 12:38","pubTimestamp":1774499930,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，该公司将于2026年6月22日派发末期股息每股0.4港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","VIG","01681","BK1191","BK1606"],"gpt_icon":0},{"id":"2622888014","title":"康臣藥業(01681)發布年度業績，股東應占溢利10.78億元 按年增加18.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622888014","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622888014?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 12:07","pubTimestamp":1774498066,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业 发布截至2025年12月31日止年度业绩，该集团取得收入人民币34.17亿元，同比增加15.17%;公司权益股东应占溢利10.78亿元，同比增加18.41%;每股基本盈利1.27元，拟派发末期股息每股0.4港元。肾科药物的销售收入于2025年约为24.0亿元，较上年同比增长约20.3%，持续领跑肾病现代中成药品类。尿毒清颗粒海外拓展也颇有成效，成功登陆印尼市场并登上当地学术舞台。妇儿药物的销售收入于2025年为3.76亿元，较上年同比增长约 4.0%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业(01681)发布年度业绩，股东应占溢利10.78亿元 同比增加18.41%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1191","01681"],"gpt_icon":0},{"id":"2622883858","title":"培力農本方(01498)發布年度業績 淨虧損3522.3萬港元 按年收窄0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622883858","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622883858?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 07:06","pubTimestamp":1774480013,"startTime":"0","endTime":"0","summary":"智通财经APP讯，培力农本方(01498)发布截至2025年12月31日止年度业绩，集团收入3.36亿港元，同比减少12%;净亏损3522.3万港元，同比收窄0.6%;基本每股亏损8.41港仙。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419172.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1606","01498"],"gpt_icon":0},{"id":"2622026613","title":"《盈警》現代中藥集團(1643.HK)料去年轉蝕不少於1,300萬人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2622026613","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622026613?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 16:38","pubTimestamp":1774427880,"startTime":"0","endTime":"0","summary":"现代中药集团(1643.HK)公布，预计2025年度录得净亏损不少于1,300万元人民币，而2024年度则录得净溢利约970万元人民币。由盈转亏主要原因为：(i)部分经销商流失；(ii)畅销产品如山玫胶囊因医保改革未被列入国家医保名单，导致销售额下降；(iii)采购订单减少，单位固定成本居高不下；(iv) 列入医保目录的产品因降低销售价格，导致整体毛利率下降。(ec/a)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220808150834405_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220808150834405_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1512372/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1512372/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1606","UCmain","CNHmain","BK1191","MUCmain","MCNHmain","01643","CYB"],"gpt_icon":0},{"id":"2622026840","title":"現代中藥集團：預計2025年度淨虧損不少於人民幣1300萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622026840","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622026840?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 16:36","pubTimestamp":1774427760,"startTime":"0","endTime":"0","summary":"南财智讯3月25日电，现代中药集团（01643.HK）发布盈利预警公告，预计公司截至2025年12月31日止年度将录得净亏损不少于人民币1300万元，而2024年度同期录得约人民币970万元的净利润。业绩由盈转亏主要因部分经销商流失、主力产品山玫胶囊未纳入国家医保目录致销售额下降、采购订单减少导致单位固定成本上升，以及进入医保目录的其他产品降价销售致整体毛利率下滑所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603253684064722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1606","01643","BK1191"],"gpt_icon":0},{"id":"2622025460","title":"Modern Chinese Medicine Group FY2025 net result drops to at least RMB13 million loss due to distributor losses and medical insurance list changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2622025460","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622025460?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 16:34","pubTimestamp":1774427674,"startTime":"0","endTime":"0","summary":"Modern Chinese Medicine Group FY2025 net result drops to at least RMB13 million loss due to distributor losses and medical insurance list changes. The outlook deteriorated due to loss of some distributors and lower sales after Cardiotonic Enhancement Capsule  was excluded from the national medical insurance list.Results also fell on reduced purchase orders that kept unit fixed costs high and on lower gross margin due to price cuts for other products in the insurance catalog.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modern Chinese Medicine Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 25, 2026, and is solel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL5RPcR4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","01643"],"gpt_icon":0},{"id":"2622204501","title":"中智藥業(03737)股價上升8.974%，現價港幣$0.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2622204501","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622204501?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 11:15","pubTimestamp":1774408500,"startTime":"0","endTime":"0","summary":"[上升股]中智药业(03737) 股价在上午11:15比前收市价上升8.974%，现股价为港币$0.85。至目前为止，今日最高价为$0.85，而最低价为$0.8。总成交量为11.8万股，总成交金额为港币$9.766万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603252914/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603252914/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03737","BK1191","BK1606"],"gpt_icon":0},{"id":"2621374290","title":"現代中藥集團(01643)股價上升8.537%，現價港幣$1.78","url":"https://stock-news.laohu8.com/highlight/detail?id=2621374290","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621374290?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 11:34","pubTimestamp":1774323240,"startTime":"0","endTime":"0","summary":"[上升股]现代中药集团(01643) 股价在上午11:34比前收市价上升8.537%，现股价为港币$1.78。至目前为止，今日最高价为$1.78，而最低价为$1.64。总成交量为95.7万股，总成交金额为港币$163.998万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603242731/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603242731/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01643","BK1191","BK1606"],"gpt_icon":0},{"id":"2621387290","title":"廣藥白雲山曬成績單：戰略轉向初見成效 2025年營利雙增","url":"https://stock-news.laohu8.com/highlight/detail?id=2621387290","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621387290?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 07:21","pubTimestamp":1774308060,"startTime":"0","endTime":"0","summary":"3月20日晚，广药集团旗下上市公司白云山（600332.SH）发布2025年年报。数据显示，白云山去年业绩实现营利双增：全年营业收入776.56亿元，同比增长3.55%；利润总额36.90亿元，同比增长2.28%；归母净利润29.83亿元，同比增长5.21%。值得注意的是，2025年是李小军履新广药集团董事长后全面掌舵的一年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603243681438361.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603243681438361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1606","BK1515","BK0196","BK0097","BK0239","BK0183","00874","600332","BK0028","BK0012","BK0175","BK1197","BK1521","BK0096","BK0188","BK1191","BK0070"],"gpt_icon":0},{"id":"2621070393","title":"培力農本方(01498.HK)完成發行2000萬港元可換股債券","url":"https://stock-news.laohu8.com/highlight/detail?id=2621070393","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621070393?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 20:07","pubTimestamp":1774267621,"startTime":"0","endTime":"0","summary":"　　董事会宣布，可换股债券认购协议项下之所有条件均已达成。可换股债券认购协议已于2026年3月23日完成，根据其条款及条件，本金总额为2000万港元的可换股债券已发行予认购人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260323/32091066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01498","BK1191","BK1606"],"gpt_icon":0},{"id":"2621775114","title":"綠葉製藥(02186)出現大手賣出82萬股，成交價$2.32，涉資190.24萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2621775114","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621775114?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 16:08","pubTimestamp":1774253280,"startTime":"0","endTime":"0","summary":"[大手成交]绿叶制药(02186)在下午04:08出现大手卖出，成交量为82万，成交价为港币$2.32，涉资190.24万。至目前为止，股价跌1.695%，今日最高价为$2.35，而最低价为$2.26，总成交量为1.477千万股，总成交金额港币$3.392千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2603239857/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2603239857/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02186","BK1606","BK1583","BK1191"],"gpt_icon":0},{"id":"2621712838","title":"白雲山「國產偉哥」金戈銷量、收入連續兩年下滑，2025年賣出約7987萬片","url":"https://stock-news.laohu8.com/highlight/detail?id=2621712838","media":"红星资本局","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621712838?lang=zh_tw&edition=fundamental","pubTime":"2026-03-22 19:03","pubTimestamp":1774177380,"startTime":"0","endTime":"0","summary":"红星资本局3月22日消息，3月21日，中药龙头白云山（600332.SH；0874.HK）发布了2025年年报，全年实现营收776.56亿元，同比增长3.55%；归母净利润29.83亿元，同比增长5.21%。与2024年营收下滑三成相比，白云山2025年业绩实现止跌回升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603223679760280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0028","00874","BK0012","BK0097","BK0239","600332","BK1197","BK1515","BK1606","BK0183","BK0096","BK0196","BK0070","BK1191","BK1521","BK0188","BK0175"],"gpt_icon":0},{"id":"2621719179","title":"中國中藥2025年淨虧損4.58億元 營業額下降10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621719179","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621719179?lang=zh_tw&edition=fundamental","pubTime":"2026-03-22 16:05","pubTimestamp":1774166700,"startTime":"0","endTime":"0","summary":"3月20日，中国中药（00570）发布全年业绩公告，截至2025年12月31日止年度，公司的营业额为147.45亿元，同比下降10.7%。毛利为70.91亿元，同比下降9.7%。本年度净亏损为4.58亿元，基本每股亏损为6.79元。管理层讨论与分析中提到，营业收入的下降主要受中药配方颗粒业务集采降价和市场竞争加剧的影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603223679731167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1191","BK1606","00570"],"gpt_icon":0},{"id":"2621719165","title":"白雲山擬每股派發現金紅利0.45元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621719165","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621719165?lang=zh_tw&edition=fundamental","pubTime":"2026-03-22 16:03","pubTimestamp":1774166580,"startTime":"0","endTime":"0","summary":"3月20日，白云山（600332/00874）发布公告，公司拟向全体股东每股派发现金红利0.45元（含税），预计总派发金额为7.32亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603223679731212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK0239","600332","BK0012","BK0183","BK1197","BK0096","00874","BK1191","BK1606","BK0188","BK1521","BK0028","BK0070","BK0175","BK0097","BK0196"],"gpt_icon":0},{"id":"2621166027","title":"《業績》同仁堂國藥(03613.HK)全年純利3.97億元跌20.6%  連特別息派40仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2621166027","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621166027?lang=zh_tw&edition=fundamental","pubTime":"2026-03-22 14:47","pubTimestamp":1774162020,"startTime":"0","endTime":"0","summary":"同仁堂国药(03613.HK) 公布2025年度业绩，收入15.13亿元，按年下降6.1%。录得纯利3.97亿元，倒退20.6%，每股盈利47仙。末期息37仙，另派特别息3仙。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-03-20 16:25。)过往派息公布日期派息事项派息内容2025/08/22中期业绩无派息2025/03/28末期业绩股息：港元 0.35002024/08/30中期业绩无派息2024/03/14末期业绩股息：港元 0.3300AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20191230151211164_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20191230151211164_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511151/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511151/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03613","BK1191","BK1606"],"gpt_icon":0},{"id":"2621757877","title":"國藥藥材品牌授權亂象","url":"https://stock-news.laohu8.com/highlight/detail?id=2621757877","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621757877?lang=zh_tw&edition=fundamental","pubTime":"2026-03-21 04:10","pubTimestamp":1774037429,"startTime":"0","endTime":"0","summary":"“央企品质特供”“中国新中式滋补行业第一央企”“世界500强第80位”……近日，《中国经营报》记者注意到，在多个电商平台，有许多标注“国药药材”品牌的中药保健品、饮片在大量销售，这些商品甚至直接使用国药集团权威背景信息。国药药材全称为国药药材股份有限公司，曾因拖欠上市公司华仁药业（300110.SZ）14亿元以及多次被国药集团打假而在业内“闻名”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603213679341730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00570","BK0239","BK0102","BK1191","BK1515","BK1606","300110"],"gpt_icon":0},{"id":"2620732957","title":"中國中藥(00570)發布年度業績 淨虧損4.58億元 按年盈轉虧","url":"https://stock-news.laohu8.com/highlight/detail?id=2620732957","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620732957?lang=zh_tw&edition=fundamental","pubTime":"2026-03-20 22:31","pubTimestamp":1774017086,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国中药(00570)发布截至2025年12月31日止年度业绩，集团营业额人民币147.45亿元，同比减少10.7%;净亏损4.58亿元，同比盈转亏;每股基本亏损6.79分。公告称，期间亏损主要由于中药配方颗粒业务受集采业务占比提高、市场竞争加剧等影响，收入规模及盈利能力下降;及本期商誉减值、无形资产减值及信用减值增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"中国中药(00570)发布年度业绩 净亏损4.58亿元 同比盈转亏","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","00570","BK1191","BK1515"],"gpt_icon":0},{"id":"2620326037","title":"白雲山(00874)將派發末期股息每股0.45元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620326037","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620326037?lang=zh_tw&edition=fundamental","pubTime":"2026-03-20 22:28","pubTimestamp":1774016936,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(00874)发布公告，将派发截至2025年12月31日止年度的末期股息每股0.45元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0175","BK4588","BK0028","BK0097","BK1606","BK0196","VIG","BK0070","BK0096","BK1521","BK0188","BK0183","BK1197","BK0239","BK4585","00874","BK0012","600332","BK1191","BK1515"],"gpt_icon":0},{"id":"2620502739","title":"同仁堂國藥(03613)將於6月26日派發末期股息每股0.37港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620502739","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620502739?lang=zh_tw&edition=fundamental","pubTime":"2026-03-20 21:04","pubTimestamp":1774011887,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同仁堂国药(03613)发布公告，将于2026年6月26日派发截至2025年12月31日止年度的末期股息每股0.37港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","BK1191","VIG","03613","BK1606"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}]}}